Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,375 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06612125Recruiting
Comparing breathing support methods in children having hernia surgery
This trial compares two different ways of giving breathing support during laparoscopic hernia repair surgery in young children. It may be a good fit if your child is between 1 and 5 years old, generally healthy, and scheduled for this specific surgery.
BenisuefAges 1–5 - NCT06474156Recruiting
Treatment motivation in forensic youth treatment (MOTIV8)
This study looks at how motivated young people are during residential MDFT treatment. It aims to understand what helps them stay engaged and succeed.
SassenheimAges 12–24 - NCT05945719Recruiting
Study on harassment discrimination against pain staff
This study focuses on adult people living with chronic pain. It may be looking at how patient behavior and workplace discrimination or harassment affect pain care staff.
Surrey, British ColumbiaAges 20–99 - NCT05606536Recruiting
Test whether IV fluid rate affects small blood flow
This study looks at whether changing how fast IV fluids are given during certain surgeries affects the body’s smallest blood vessels. You may be able to join if your surgery is planned and you meet safety limits.
Hradec KrálovéAges 18 years+ - NCT07636135Recruiting
Early rehabilitation timing after neck spine surgery
This study tests whether starting physical therapy sooner after neck spine surgery for degenerative myelopathy (a condition where the spinal cord is compressed) helps patients recover strength, balance, and walking ability faster. You'll do 8 weeks of in-person rehabilitation in Edmonton, Alberta.
Edmonton, AlbertaAges 18 years+ - NCT06514898RecruitingPhase 1
Personalized cell therapy for recurrent medulloblastoma
This trial tests a combination of personalized immune cells, vaccines, stem cells, and an immunotherapy drug (pembrolizumab) for children and young adults whose medulloblastoma has come back or grown. The goal is to help the immune system fight the cancer more effectively.
Washington D.C., District of ColumbiaAges 4–30 - NCT07753330Recruiting
Anxiety treatment study
This study tests a new type of therapy that focuses on facing fears to help reduce anxiety. It may be a good fit if you have an anxiety disorder and are looking for treatment.
Santiago, Santiago MetropolitanAges 18–70 - NCT06860542RecruitingPhase 2
Inhaled steroid to prevent lung inflammation from returning after immunotherapy
This trial tests whether using an inhaled steroid (budesonide) can help prevent lung inflammation (pneumonitis) from coming back in people who have had it caused by immunotherapy cancer treatment. It may be an option for patients who need extra support after their first bout of this side effect.
Calgary, AlbertaAges 18 years+ - NCT07704918Recruiting
Study: Lowering cholesterol during melanoma immunotherapy
This study tests whether giving aggressive cholesterol-lowering medication to people starting immunotherapy for melanoma can improve heart health. It may help reduce the risk of heart problems during cancer treatment.
Aurora, ColoradoAges 55 years+ - NCT07254806RecruitingPhase 3
Cell therapy for low back pain from disc disease
This study tests if injecting a special cell therapy into a damaged spinal disc can reduce chronic low back pain. It is for people who have had low back pain for at least 6 months and haven't gotten enough relief from other treatments like physical therapy or pain medication.
Birmingham, AlabamaAges 18–75 - NCT06017817Recruiting
Light therapy for implant gum disease
This study tests a special light-activated treatment (antibacterial photodynamic therapy) to fight infection around dental implants. It may be an option for people with moderate to severe implant-related gum disease who are not smokers and do not have diabetes.
StockholmAges 18–85 - NCT07752030Enrolling by invitation
Measuring treatment effects in cerebral palsy
This study looks at how well different treatments work for people with cerebral palsy. It may help doctors understand which treatments are best for improving walking and movement.
Omaha, NebraskaAges 16–30 - NCT06285825RecruitingPhase 2
Study of emapalumab for low blood counts after CAR T-cell therapy
This study tests a drug called emapalumab to help people whose blood counts stay low for weeks after CAR T-cell therapy for certain types of lymphoma. The goal is to see if the drug can help the body recover normal blood cell production.
Houston, TexasAges 18 years+ - NCT07242352RecruitingPhase 3
Comparing elacestrant to standard hormone therapy for high-risk early breast cancer
This trial tests a new hormone therapy drug called elacestrant against standard hormone treatments for people with a specific type of early breast cancer (ER+/HER2-) that has a high chance of coming back. The goal is to see if elacestrant works better at keeping the cancer from returning.
Mannheim, Baden-WurttembergAges 18 years+ - NCT07052929RecruitingPhase 1/Phase 2
Gene therapy study for young boys with XLMTM on ventilators
This study tests a new gene therapy called ASP2957 in young boys with X-linked myotubular myopathy who are dependent on a ventilator. The goal is to see if it can help improve their breathing and muscle strength.
Chicago, IllinoisAges Up to 3 years - NCT06575374RecruitingPhase 2
Letermovir to prevent CMV after CAR T-cell therapy
This trial tests if a drug called letermovir can safely prevent CMV (a common virus) from reactivating after you receive CAR T-cell therapy (Axi-cel). It may help reduce infections and side effects.
Houston, TexasAges 18 years+ - NCT07448844RecruitingPhase 4
Comparing vitamin D3 and acyclovir shots for skin warts
This trial tests two injected treatments (vitamin D3 or acyclovir) for common skin warts. The goal is to see which one works better for warts that are new or have not gone away with other treatments.
Rawalpindi, Punjab ProvinceAges 12 years+ - NCT07048600Recruiting
Brief trial of ACT-i for adults with chronic insomnia
This trial tests a psychological treatment called ACT-i for people with chronic insomnia (trouble sleeping for a long time). It aims to see if this online therapy can help improve sleep without drugs.
Cluj-NapocaAges 18–59 - NCT06615206Recruiting
First CRISPR RNA therapy for MECP2 duplication syndrome
This trial tests a new CRISPR therapy that edits RNA to treat a rare genetic condition called MECP2 duplication syndrome (MDS). It is for boys aged 2 to 18 who have stable seizures and no other major health problems, with the goal of improving symptoms and safety.
Beijing, Beijing MunicipalityAges 2–18 - NCT06458764Recruiting
Checking sexual health in younger breast cancer survivors on hormone therapy
This study is checking how hormone therapy affects sexual health in younger women who had early-stage breast cancer. You'll fill out questionnaires about your sexual function and well-being.
Torino, TOAges 18–55 - NCT06330142Recruiting
Horsing around during radiotherapy for kids
This study tests if spending time with horses (hippotherapy) can help children aged 8 to 17 feel better during cancer radiation treatment. It aims to see if this activity improves quality of life and reduces stress.
StrasbourgAges 8–17 - NCT06314334RecruitingPhase 2
Chemotherapy plus radiation for early-stage NK/T-cell lymphoma
This trial tests whether combining chemotherapy with radiation therapy can work well for people with early-stage NK/T-cell lymphoma that started in the nose or throat. It aims to find a more effective treatment approach with fewer side effects.
Fuzhou, FujianAges 18–75 - NCT06246630Recruiting
Personalized drug testing for advanced pancreatic neuroendocrine tumors
This trial uses a lab-grown model of your tumor (called an organoid) to test which drugs might work best for you. It is for people with advanced pancreatic neuroendocrine tumors who cannot have surgery.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05938101Recruiting
Pain clinic study on adult chronic pain
This study focuses on adult people with ongoing (chronic) pain. It’s looking at experiences with pain clinic staff during the time around COVID.
Surrey, British ColumbiaAges 20–99
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,375 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.